The stock opened at Rs 5952.05 and touched an intraday high and low of Rs 6098.4 and Rs 5952.05, respectively, in the session so far. The stock of Divi’s Laboratories Ltd. quoted a 52-week high of Rs 6098.4 and a 52-week low of Rs 3300.0.
As per BSE, the total market cap of the Divi’s Laboratories Ltd. stood at Rs 160700.08 crore at the time of writing this report.
Key Financials
The company reported consolidated net sales of Rs 2197.0 crore for the quarter ended 30-Jun-2024, down 7.77 per cent from previous quarter’s Rs 2382.0 crore and down 18.18 per cent from the year-ago quarter’s Rs 1859.0 crore.
-
Stock Trading
Market 103: Mastering Trends with RMI and Techno-Funda Insights
-
Stock Trading
Technical Analysis for Everyone – Technical Analysis Course
-
Stock Trading
RSI Made Easy: RSI Trading Course
-
Stock Trading
Technical Analysis Made Easy: Online Certification Course
-
Stock Trading
ROC Made Easy: Master Course for ROC Stock Indicator
-
Stock Trading
Renko Chart Patterns Made Easy
-
Stock Trading
Commodity Markets Made Easy: Commodity Trading Course
-
Stock Trading
Markets 102: Mastering Sentiment Indicators for Swing and Positional Trading
-
Stock Trading
Cryptocurrency Made Easy: Cryptocurrency Course
-
Stock Trading
A2Z of Stock Market for Beginners: Stock Market Course For Beginners
-
Stock Trading
Dow Theory Made Easy
-
Stock Trading
Technical Trading Made Easy: Online Certification Course
-
Stock Trading
Futures Trading Made Easy: Future & Options Trading Course
-
Stock Trading
Stock Valuation Made Easy
-
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
-
Stock Trading
A2Z of Stock Trading – Online Stock Trading Course
-
Stock Trading
Options Scalping Made Easy
The net profit for latest quarter stood at Rs 430.0 crore, up 20.79 per cent from the same quarter a year ago.
Shareholding pattern
As of 30-Jun-2024, DIIs held 13.1 per cent stake in the firm, while foreign institutional investors held 16.16 per cent and the promoters 51.9 per cent.
Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 96.0 and a price-to-book ratio of 6.71. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Divi’s Laboratories Ltd. belongs to the Pharma – Indian industry.
